Skip to content

Protective Analgesia for Postoperative Pain Relief Following Day Case Oral Surgery

Protective Analgesia Using Bupivacaine and Conventional Release Ibuprofen Versus Bupivacaine and Sustained Release Ibuprofen for Postoperative Pain Relief in Patients Undergoing Third Molar Surgery: a Randomised Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00895843
Enrollment
122
Registered
2009-05-08
Start date
2006-11-30
Completion date
2008-01-31
Last updated
2009-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Pain, Wisdom Tooth

Keywords

Third molar

Brief summary

The purpose of this study is to investigate whether robust analgesic regime (protective analgesia) can improve postoperative pain experience for patients undergoing lower wisdom teeth extraction under day case general anaesthetic.

Detailed description

The aim of the study was to demonstrate and improve postoperative pain experience using protective analgesia for patients undergoing oral surgery under day case general anaesthesia. The primary objective was to investigate the efficiency of protective analgesia using combined effects of sustained release ibuprofen and bupivacaine nerve block in attenuation of postoperative pain following impacted third molar surgery under day case general anaesthesia. The secondary objective was to document the safety and tolerability profile of conventional release versus sustained released ibuprofen with bupivacaine block in subjects undergoing impacted third molar surgery under day case general anaesthesia.

Interventions

Single dose 2 x 800mg tablets 2 hours prior to surgery

DRUGibuprofen

Single dose ibuprofen 2 x 200mg tablets 2 hours prior to surgery

DRUGBupivacaine

Up to 10ml of Bupivacaine 0.5% with 1:200,000 Adrenaline given prior to surgical incision as inferior alveolar nerve block and long buccal nerve infiltration.

Sponsors

Manchester University NHS Foundation Trust
CollaboratorOTHER_GOV
University of Manchester
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy male and female patients aged 18 years and over * patients requiring removal of one or more third molars, with at lease one completely or partially impacted in the mandible needing bone removal

Exclusion criteria

* history of allergy to NSAIDs * pregnant * history of GI disease * history of bleeding disorders * alcohol dependancy * drug abuse

Design outcomes

Primary

MeasureTime frameDescription
Number of Patients Needing Rescue MedicationAt 6 hoursNumber of patients who required rescue medication within 6 hours

Secondary

MeasureTime frameDescription
Mean Pain Intensity30 mins, 1 hour, 6 hours, 24 hours and 48 hours after surgeryMean VAS scores of pain intensity for each time points
Time to RescueBetween 30mins and 48 hoursTime taken for rescue medication requirement
Pain Control/Relief48 hours after surgery (end of study)Patient satisfaction scores

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
Conventional Ibuprofen60
Brufen Retard62
Total122

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyProtocol Violation1212

Baseline characteristics

CharacteristicBrufen RetardConventional IbuprofenTotal
Age, Categorical
<=18 years
0 Participants0 Participants0.0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0.0 Participants
Age, Categorical
Between 18 and 65 years
62 Participants60 Participants122.0 Participants
Age Continuous28.82 years
STANDARD_DEVIATION 6.262
28.71 years
STANDARD_DEVIATION 5.809
28.77 years
STANDARD_DEVIATION 6.013
Region of Enrollment
United Kingdom
62 participants60 participants122.0 participants
Sex: Female, Male
Female
16 Participants40 Participants56.0 Participants
Sex: Female, Male
Male
46 Participants20 Participants66.0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
— / —— / —
serious
Total, serious adverse events
— / —— / —

Outcome results

Primary

Number of Patients Needing Rescue Medication

Number of patients who required rescue medication within 6 hours

Time frame: At 6 hours

ArmMeasureValue (NUMBER)
Conventional IbuprofenNumber of Patients Needing Rescue Medication32 Participants
Brufen RetardNumber of Patients Needing Rescue Medication29 Participants
Secondary

Mean Pain Intensity

Mean VAS scores of pain intensity for each time points

Time frame: 30 mins, 1 hour, 6 hours, 24 hours and 48 hours after surgery

Secondary

Pain Control/Relief

Patient satisfaction scores

Time frame: 48 hours after surgery (end of study)

Secondary

Time to Rescue

Time taken for rescue medication requirement

Time frame: Between 30mins and 48 hours

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026